History of the Transplant Institute

30 Years of Organ Transplant Surgery Experience and Expertise in Dallas, Texas

Throughout its history, the Methodist Dallas Transplant program has maintained a commitment to innovation in transplant medicine. Since the first organ transplant at Methodist Dallas more than 30 years ago, independently practicing physicians on the medical staff have regularly participated in research that helps advance transplant medicine and dramatically increases organ transplant surgery success rates.

2013undefined
Methodist's First Paired Donor Exchange Transplant

Methodist's first Altruistic donor

2011
The Methodist Transplant Program celebrates the 30th anniversary of kidney transplant services.

The Liver Institute announces its involvement in several clinical trials using a newer generation of drugs for the treatment of chronic hepatitis C. The trials will focus on a second generation of direct-acting antiviral drugs for hepatitis C that are very potent and may shorten the duration of therapy in a number of patients. These antiviral drugs offer very promising hope for eradication of hepatitis C for patients who have experienced and failed treatment in the past.

2009
Methodist Dallas Transplant Institute celebrates patient number 2,700.

Methodist Dallas Transplant Institute becomes the first in the Dallas–Fort Worth Metroplex to perform a kidney transplant on an HIV-positive patient.

2008
New antibody-lowering therapy for kidney transplants is introduced.

2007
HIV-positive kidney transplant protocol is added.

2004
Two patients are successfully treated using an antibody-lowering protocol for the highly sensitized patient.

Paired exchange is offered to patients on Methodist Dallas Transplant Institute’s kidney transplant waiting list, matching a recipient-donor pair – with incompatible blood or tissue types – with another recipient-donor pair.

2003
Methodist Dallas Transplant Institute expands its service with the opening of The Liver Institute at Methodist Dallas — one of only three facilities in the Dallas–Fort Worth, Texas area that performs adult liver transplants.

In addition to performing liver transplants, The Liver Institute at Methodist Dallas offers comprehensive, and multidisciplinary care for liver disease, including:

  • Hepatitis
  • Hepatology program
  • Liver tumor program
  • Clinic for hepatobiliary and pancreatic disorders

1999
Texas’ first successful living donor laparoscopic nephrectomy is performed at the Methodist Dallas Transplant Institute. Since then almost 300 laparoscopic donor nephrectomies have been performed at the Methodist Dallas Transplant Institute.

1992
Independently practicing physicians on the Methodist Health System medical staff make worldwide history by successfully performing the world's first simultaneous heart-kidney-pancreas transplant at Methodist Dallas Medical Center.

1986
The first pancreas transplant in Dallas–Fort Worth is performed at Methodist Dallas.

The first heart transplant at the Methodist Dallas Transplant Institute is performed, furthering the hospital’s reputation as a center for comprehensive, sophisticated cardiac care and leadership in transplant medicine.

1983
The first kidney transplant for a Puerto Rican patient – the 100th transplant overall – is performed. To date, more than 325 kidney transplants have been performed on Puerto Rican patients. There are more than 100 patients from Puerto Rico on the Methodist Dallas Transplant Institute's waiting list. The Transplant Institute operates two offices in Puerto Rico.

1981
The Methodist Dallas Transplant Institute’s commitment to the Latin community begins with its first kidney transplant for a patient from Ecuador.

1980
Methodist Dallas Medical Center establishes a kidney transplant program as part of a long-standing commitment to comprehensive care for people with end-stage renal disease.

The success of this program leads to others such as pancreas transplants and combined kidney-pancreas transplants. Methodist Dallas is the first private hospital in Texas to offer this promising alternative treatment for diabetes.